11.08 am | 29 Dec 2010 |  Source: Moneycontrol.com

IIFL is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 486 in its December 29, 2010 research report....

5.11 pm | 22 Dec 2010 |  Source: CNBC-TV18

Radhika Gupta of Forefront Capital Management likes pharma space because from a fundamental perspective, Indian Pharma players are making a big mark i...

4.37 pm | 13 Dec 2010 |  Source: CNBC-TV18

In an interview with CNBC-TV18’s Latha Venkatesh, Kamal K Sharma, MD, Lupin, spoke about the latest happenings in his company and sector....

6.28 pm | 30 Nov 2010 |  Source: CNBC-TV18

Lupin and Sun Pharma are safer picks, says Anil Manghnani of Modern Shares & Stock Brokers....

3.04 pm | 30 Nov 2010 |  Source: CNBC-TV18

Technical Analyst, Ashwani Gujral is positive on Lupin, IndusInd Bank....

2.02 pm | 30 Nov 2010 |  Source: CNBC-TV18

Technical Analyst, Ashwani Gujral is of the view that one can buy Lupin with a target of Rs 540 per share and stop loss at Rs 495 per share....

6.37 pm | 29 Nov 2010 |  Source: CNBC-TV18

Ashwani Gujral, Technical Analyst is positive on Lupin and Aurobindo Pharma....

2.40 pm | 29 Nov 2010 |  Source: CNBC-TV18

The December launch of AllerNaze is delayed due to packaging issues, CFO of Lupin S Ramesh said. “We have postponed it indefinitely, but we could expe...

10.32 am | 19 Nov 2010 |  Source: CNBC-TV18

Lupin has target of Rs 566, says Anil Manghnani of Modern Shares & Stock Brokers....

5.09 pm | 01 Nov 2010 |  Source: CNBC-TV18

Lupin's Q2 net profit came in at Rs 215 crore as compared to Rs 160 crore, a growth of 34.375% on a year-on-year basis. In an interview with CNBC-TV18...

2.09 pm | 01 Nov 2010 |  Source: Moneycontrol.com

Drug firm Lupin has announced its results for the quarter ended September 2010. It has reported consolidated net profit at Rs 215 crore as against Rs ...

9.59 am | 01 Nov 2010 |  Source: Moneycontrol.com

Drug firm Lupin is set to announce its results for the quarter ended September 2010. According to CNBC-TV18 estimates, its profit after tax (PAT) is e...

9.42 am | 28 Oct 2010 |  Source: CNBC-TV18

Buy Lupin November Futures at 455, says VK Sharma of HDFC Securities....

4.09 pm | 20 Oct 2010 |  Source: CNBC-TV18

Lupin can touch Rs 485, says Akshata Deshmukh, Sr Research Analyst, Networth Stock Broking....

11.19 am | 13 Oct 2010 |  Source: Moneycontrol.com

IIFL is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 440 in its October 13, 2010 research report....

4.02 pm | 09 Oct 2010 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earning estimates on Pharmaceutical sector for the quarter ended September 2010....

10.51 am | 05 Oct 2010 |  Source: Moneycontrol.com

IIFL is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 425 in its October 5, 2010 research report....

2.55 pm | 24 Sep 2010 |  Source: Reuters

Indian pharma major Lupin Ltd expects continued growth in US sales this fiscal on its rising branded and generics business, a top official said late o...

10.45 am | 20 Sep 2010 |  Source: CNBC-TV18

Lupin can move upto Rs 397-400, says Anu Jain of IIFL Private Wealth Management....

3.32 pm | 17 Sep 2010 |  Source: CNBC-TV18

Lupin has target of Rs 450, says Technical Analyst, Ashwani Gujral....